Jenscare Scientific Co., Ltd. provided the shareholders and potential investors of the Company with updated information in relation to the latest business and new product development of the Group. The board of directors of the company announced that JensClip, the self-developed clip-based TMVr system for the treatment of severe mitral regurgitation, has recently completed the enrollment for confirmatory clinical trial and the one-month clinical follow-up with outstanding clinical results. JensClip utilizes its claw wall and a locking mechanism, with a structural design that can grasp the valve leaflets bilaterally, which can effectively reduce regurgitation.

In addition, the delivery system of JensClip is designed to enable physicians to maneuver the device from a 360-degree perspective with ease and high flexibility. The company is on track to promote its proprietary innovative medical devices and thereby benefit more patients and realize the company's internationalization strategy.